Fidelity MSCI Health Care Index ETF

Fidelity's Health Care ETF Holds the Biotechs XLV Skips. Retirees Should Know the Difference

Two health care ETFs track the same sector but own very different slices of it, and for retirees building a portfolio, that gap in biotech exposure and concentration could matter more than the nearly identical returns suggest.

Which Healthcare ETF Is the Better Buy: Fidelity's FHLC or State Street's XLV?

State Street Health Care Select Sector SPDR ETF focuses exclusively on S&P 500 healthcare components, leading to a highly concentrated portfolio. Fidelity MSCI Health Care Index ETF provides broader industry exposure and reaches deeper into mid-cap and small-cap segments.

7,458 Shares in Fidelity MSCI Health Care Index ETF $FHLC Purchased by LexAurum Advisors LLC

Better Buy: Fidelity Health Care ETF (FHLC) or iShares Biotechnology ETF (IBB)?

Fidelity MSCI Health Care Index ETF offers a significantly lower expense ratio of 0.08% compared to 0.44% for the iShares Biotechnology ETF. iShares Biotechnology ETF is more concentrated, with 87% of its portfolio in biotechnology stocks.

Which Healthcare ETF Is the Better Buy: Fidelity’s Broad FHLC or Invesco’s Biotech-Focused PBE?

One offers broad diversification at 0.08% cost, while the other targets concentrated biotech growth with higher volatility.

Rockland Trust Co. Buys 28,319 Shares of Fidelity MSCI Health Care Index ETF $FHLC

Rockland Trust Co. bought a new position in shares of Fidelity MSCI Health Care Index ETF (NYSEARCA:FHLC) in the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor bought 28,319 shares of the company's stock, valued at approximately $2,314,000. Rockland Trust Co.

Better Healthcare ETF: Fidelity's Broad, Low-Cost FHLC vs. State Street's XBI Targeting Biotech

The Fidelity MSCI Health Care Index ETF offers a significantly lower expense ratio and a more diversified portfolio than the State Street SPDR S&P Biotech ETF. The State Street SPDR S&P Biotech ETF experienced a much deeper maximum drawdown over the last five years but outperformed on a 1-year total return basis.

Fidelity Healthcare ETF (FHLC) vs. VanEck Biotech ETF (BBH): Which Fund Is the Better Buy?

FHLC features a much lower expense ratio of 0.08% compared to 0.35% for BBH. BBH is a concentrated portfolio of just 26 stocks, while FHLC holds around 350 companies.